Process development and safety evaluation of ABCB5+ limbal stem cells as advanced-therapy medicinal product to treat limbal stem cell deficiency.

Autor: Norrick, Alexandra1 (AUTHOR), Esterlechner, Jasmina1 (AUTHOR), Niebergall-Roth, Elke1 (AUTHOR), Dehio, Ulf2 (AUTHOR), Sadeghi, Samar1 (AUTHOR), Schröder, Hannes M.2 (AUTHOR), Ballikaya, Seda1 (AUTHOR), Stemler, Nicole1 (AUTHOR), Ganss, Christoph1,2 (AUTHOR), Dieter, Kathrin2 (AUTHOR), Dachtler, Ann-Kathrin2 (AUTHOR), Merz, Patrick3,4 (AUTHOR), Sel, Saadettin4 (AUTHOR), Chodosh, James5 (AUTHOR), Cursiefen, Claus6,7 (AUTHOR), Frank, Natasha Y.8,9,10,11 (AUTHOR), Auffarth, Gerd U.3,4 (AUTHOR), Ksander, Bruce12 (AUTHOR), Frank, Markus H.10,11,13,14 (AUTHOR), Kluth, Mark A.1,2 (AUTHOR) andreas.kluth@ticeba.com
Zdroj: Stem Cell Research & Therapy. 3/19/2021, Vol. 12 Issue 1, p1-21. 21p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje